ALSO NOTED: Becker takes the CEO spot at VIOQuest; J&J makes big changes; and much more...

> We figure Warren Buffett (photo) liked the idea. First, Berkshire Hathaway boosted its stake in Johnson & Johnson. Now, J&J has announced a sweeping reorganization. Report

> Chutes & Ladders: At the beginning of the week, Michael Becker was CEO of Cytogen. Now he's the CEO of VioQuest. Daniel Greenleaf resigned from VioQuest to pursue "other opportunities." Release

> Apotex has acquired Topgen of Belgium from Zambon. No acquisition price was disclosed. Release

> The FDA has spoken--and GlaxoSmithKline is breathing a sigh of relief. The agency did stiffen warnings on the embattled diabetes med Avandia, but it shied away from linking the drug to heart attacks. Report

> While all eyes were on other potential mergers, Hungary's Richter Gedeon made two deals that will boost it to the top of Central and Eastern Europe's pharma industry. Report

> Prompted by a study suggesting the drug may increase the risk of death, FDA has embarked on a safety review of Maxipime, a Bristol-Myers Squibb antibiotic. Report 

And Finally... An Iowa State professor makes the case that violent video games teach aggression. Release